NYSE US 100
18.639,98
PKT
-169,42
PKT
-0,90
%
Werbung
Analysen zu NYSE US 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.02.12 | AT&T halten | Independent Research GmbH | |
| 01.02.12 | Pfizer halten | Independent Research GmbH | |
| 01.02.12 | Carnival equal-weight | Barclays Capital | |
| 01.02.12 | ExxonMobil neutral | Sarasin Research | |
| 01.02.12 | Illinois Tool Works outperform | Barrington Research | |
| 01.02.12 | ExxonMobil kaufen | National-Bank AG | |
| 01.02.12 | Altria halten | Independent Research GmbH | |
| 01.02.12 | McDonalds overweight | Piper Jaffray & Co. | |
| 31.01.12 | Bayer buy | Banc of America Securities-Merrill Lynch | |
| 31.01.12 | Bank of America neutral | Goldman Sachs Group Inc. | |
| 31.01.12 | Citigroup buy | Goldman Sachs Group Inc. | |
| 31.01.12 | Honeywell buy | Nomura | |
| 31.01.12 | Dominion Energy sector perform | RBC Capital Markets | |
| 31.01.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 31.01.12 | Chevron overweight | Barclays Capital | |
| 31.01.12 | Illinois Tool Works outperform | Barrington Research | |
| 31.01.12 | Coca-Cola buy | Stifel, Nicolaus & Co., Inc. | |
| 31.01.12 | Halliburton overweight | JP Morgan Chase & Co. | |
| 30.01.12 | Honeywell outperform | Oppenheimer & Co. Inc. | |
| 30.01.12 | Chevron halten | Independent Research GmbH | |
| 30.01.12 | Procter Gamble neutral | UBS AG | |
| 30.01.12 | Chevron buy | Société Générale Group S.A. (SG) | |
| 30.01.12 | Honeywell neutral | UBS AG | |
| 30.01.12 | Procter Gamble buy | Sarasin Research | |
| 30.01.12 | 3M neutral | Sarasin Research | |
| 30.01.12 | Chevron buy | Sarasin Research | |
| 30.01.12 | United Parcel Service neutral | Nomura | |
| 30.01.12 | Caterpillar overweight | Barclays Capital | |
| 30.01.12 | 3M reduce | Nomura | |
| 30.01.12 | Kimberly-Clark outperform | RBC Capital Markets | |
| 30.01.12 | AT&T sector perform | Scotia Capital Markets | |
| 30.01.12 | Caterpillar outperform | Raymond James Financial, Inc. | |
| 30.01.12 | Colgate-Palmolive sector perform | RBC Capital Markets | |
| 30.01.12 | Bristol-Myers Squibb overweight | Barclays Capital | |
| 30.01.12 | IBM buy | Sarasin Research | |
| 30.01.12 | AT&T buy | Nomura | |
| 27.01.12 | Exelon neutral | UBS AG | |
| 27.01.12 | Caterpillar neutral | UBS AG | |
| 27.01.12 | 3M buy | UBS AG | |
| 27.01.12 | Caterpillar buy | Sarasin Research |